Allele Biotechnology and Pharmaceuticals, Inc. v. Regeneron Pharmaceuticals, Inc.

25-1117Court of Appeals for the Federal CircuitDec 31, 2024

Full text

NOTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
ALLELE BIOTECHNOLOGY AND
PHARMACEUTICALS, INC.,
Plaintiff-Appellee
v.
REGENERON PHARMACEUTICALS, INC.,
Defendant-Appellant
______________________
2025-1117
______________________
Appeal from the United States District Court for the
Southern District of New York in No. 7:20-cv-08255-PMH,
Judge Philip M. Halpern.
______________________
O R D E R
The parties having so agreed, it is ordered that:
(1) The proceeding is DISMISSED under Fed. R. App.
P. 42 (b).
Case: 25-1117 Document: 13 Page: 1 Filed: 12/31/2024

-- 1 of 2 --

ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, I NC. V.
REGENERON PHARMACEUTICALS, I NC.
2
(2) Each side shall bear their own costs.
FOR THE COURT
December 31, 2024
Date
ISSUED AS A MANDATE: December 31, 2024
Case: 25-1117 Document: 13 Page: 2 Filed: 12/31/2024

-- 2 of 2 --

Continue your research in ChatGPT or Claude

Connect Omnilex to search the legal corpus from your AI assistant.